Questions about this study?
The HopeStage team will email you.
WithdrawnNCT04513132
Targeted Intervention Study of DTMS on Impaired Insight in Early Psychosis
Device studyAges 15–35ChinaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 15 years to 35 years.
- Listed locations
- ShanghaiSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: January 1, 2024
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 15 Years to 35 Years
- Official registry ID
- NCT04513132
- Official title
Show the full official title
A Study on Targeted Intervention for Insight in Patients with First Episode and Clinical High Risk of Schizophrenia Based on Theta Oscillation in Anterior Cingulate Cortex
Recruitment & locations
WithdrawnShanghai
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Who can participate?
Listed age limits: 15 years to 35 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
